Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers-Reference-Cited by-同舟云学术

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

Published:2019-08-15 Issue:1 Volume:16 Page:33-41
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

von Seidlein Lorenz¹²^ORCID,Hanboonkunupakarn Borimas¹³^ORCID,Jittamala Podjanee¹³,Pongsuwan Pongphaya¹,Chotivanich Kesinee¹^ORCID,Tarning Joel¹²^ORCID,Hoglund Richard M.¹²^ORCID,Winterberg Markus¹²^ORCID,Mukaka Mavuto¹²,Peerawaranun Pimnara¹,Sirithiranont Pasathorn¹,Doran Zoe¹²,Ockenhouse Christian F.⁴,Ivinson Karen⁴,Lee Cynthia⁴^ORCID,Birkett Ashley J.⁴,Kaslow David C.⁴,Singhasivanon Pratap³,Day Nicholas P.J.¹²,Dondorp Arjen M.¹²,White Nicholas J.¹²,Pukrittayakamee Sasithon³⁵

Affiliation:

1. Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

2. Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK

3. Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

4. PATH’s Malaria Vaccine Initiative, Seattle, WA, USA

5. The Royal Society of Thailand, Dusit, Bangkok, Thailand

Funder

PATH’s Malaria Vaccine Initiative

PATH

Publisher

Informa UK Limited

Subject